Emerging data suggest this peptide, a dual agonist targeting both the gut-brain axis and another hormone, could offer a promising advancement for weight treatment. Preliminary patient investigations have indicated substantial reductions in visceral tissue, conceivably outperforming existing body composition medications . Despite this, additional ev